Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Cameli and Maria Mazzei.
Connection Strength
0.429
-
Serial KL-6 measurements in COVID-19 patients. Intern Emerg Med. 2021 09; 16(6):1541-1545.
Score: 0.058
-
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients. Ultrasound Med Biol. 2021 01; 47(1):19-24.
Score: 0.056
-
Serum KL-6 concentrations as a novel biomarker of severe COVID-19. J Med Virol. 2020 10; 92(10):2216-2220.
Score: 0.055
-
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients. Minerva Med. 2021 06; 112(3):423-426.
Score: 0.055
-
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? Medicine (Baltimore). 2019 Jun; 98(26):e16086.
Score: 0.052
-
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? Respir Med Case Rep. 2019; 27:100843.
Score: 0.051
-
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP. Inflammation. 2019 Apr; 42(2):463-470.
Score: 0.051
-
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6. Dis Markers. 2019; 2019:8565423.
Score: 0.051